-
Healthy Extracts Reports Record Q3 2025, with Revenue up 23%
-
Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025
-
Gelteq partners with Melbourne Health on bowel polyp reduction compound
-
Gelteq technology reaches US market through partner product launch
-
Gelteq begins preclinical trial for gel-based antihistamine formulation
-
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs
-
Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%
-
Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA
-
Gelteq partners with IDT Australia for manufacturing facility
-
Gelteq Limited (GELS) Files for 4M Share Offering by Selling Stockholders
-
Gelteq Limited (GELS) Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner
-
Gelteq Limited (GELS) Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC
-
Gelteq Limited (GELS) Appoints Paul Wynne as Chief Scientific Officer
-
Gelteq Limited (GELS) Receives FDA Approval of its Suitability Petition for New Animal Drug
-
Gelteq Limited (GELS) Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
-
Gelteq Limited (GELS) Announces 400,000 Units Enter into Production in November 2024
-
Gelteq (GELS) Closes $5.2M IPO
-
Gelteq (GELS) Prices 1.3M Share IPO at $4/sh

